Jupiter Asset Management Ltd. Has $1.09 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)

Jupiter Asset Management Ltd. cut its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 87.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 36,702 shares of the company's stock after selling 258,259 shares during the period. Jupiter Asset Management Ltd.'s holdings in Hims & Hers Health were worth $1,085,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. US Bancorp DE lifted its position in Hims & Hers Health by 278.6% during the 1st quarter. US Bancorp DE now owns 7,356 shares of the company's stock valued at $217,000 after purchasing an additional 5,413 shares during the period. XTX Topco Ltd boosted its position in shares of Hims & Hers Health by 105.0% in the 1st quarter. XTX Topco Ltd now owns 50,909 shares of the company's stock worth $1,504,000 after purchasing an additional 26,073 shares during the last quarter. N.E.W. Advisory Services LLC bought a new position in shares of Hims & Hers Health in the 1st quarter worth $49,000. Meeder Asset Management Inc. boosted its position in shares of Hims & Hers Health by 49,043.1% in the 1st quarter. Meeder Asset Management Inc. now owns 35,383 shares of the company's stock worth $1,046,000 after purchasing an additional 35,311 shares during the last quarter. Finally, LPL Financial LLC boosted its position in shares of Hims & Hers Health by 0.8% in the 1st quarter. LPL Financial LLC now owns 98,701 shares of the company's stock worth $2,917,000 after purchasing an additional 743 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors and hedge funds.

Hims & Hers Health Trading Up 1.3%

Shares of Hims & Hers Health stock opened at $63.38 on Tuesday. The company has a market capitalization of $14.19 billion, a PE ratio of 91.86, a PEG ratio of 2.31 and a beta of 2.08. Hims & Hers Health, Inc. has a 12 month low of $13.47 and a 12 month high of $72.98. The stock's fifty day simple moving average is $53.79 and its 200 day simple moving average is $44.51.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The firm had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. During the same period in the prior year, the business earned $0.06 EPS. The business's revenue for the quarter was up 72.6% compared to the same quarter last year. Analysts predict that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on HIMS shares. Truist Financial raised their price target on Hims & Hers Health from $45.00 to $48.00 and gave the stock a "hold" rating in a research report on Thursday, July 17th. Citigroup restated a "sell" rating on shares of Hims & Hers Health in a research report on Monday, June 23rd. Bank of America raised their price target on Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a research report on Tuesday, April 29th. Needham & Company LLC restated a "hold" rating on shares of Hims & Hers Health in a research report on Monday, June 23rd. Finally, Morgan Stanley restated an "equal weight" rating and issued a $40.00 price target on shares of Hims & Hers Health in a research report on Wednesday, June 11th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $39.83.

Insider Transactions at Hims & Hers Health

In other Hims & Hers Health news, CEO Andrew Dudum sold 125,335 shares of Hims & Hers Health stock in a transaction dated Monday, July 21st. The stock was sold at an average price of $49.54, for a total value of $6,209,095.90. Following the sale, the chief executive officer owned 92,313 shares of the company's stock, valued at $4,573,186.02. This trade represents a 57.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Soleil Boughton sold 2,572 shares of Hims & Hers Health stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $58.70, for a total value of $150,976.40. Following the completion of the sale, the insider directly owned 155,593 shares in the company, valued at $9,133,309.10. This represents a 1.63% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 737,704 shares of company stock worth $40,644,035. Company insiders own 17.71% of the company's stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.